Key advancements for Alligator Bioscience in Q2
As indicated in the financial report released this morning, Q2 was an important quarter for biotech company Alligator Bioscience. It marked the beginning of Søren Bregenholt’s tenure as CEO for the company, and it also brought positive data for Alligator’s top projects: Mitazalimab and ATOR-1017. Lund-based Alligator Bioscience released its Q2 report this report, which.